Anti-Human TGF-beta 1 Reference Antibody (Metelimumab, RUO)

Description: Research Grade Metelimumab (BS10041) is a human monoclonal antibody detecting Transforming growth factor beta-1 proprotein in ELISA, Bioactivity: FACS, Functional assay, Research in vivo. Suitable for Human.
Highlights:
• Multi-Application — Validated across multiple applications.
Host species: Human
Isotype: IgG4-kappa
Species reactivity: Human
Immunogen:
Form: Liquid
Storage instructions:
Storage buffer: 0.01M PBS, pH7.4.
Concentration: 1mg/ml
Purity: >95% as determined by SDS-PAGE.
Clonality: Monoclonal
Applications: Research Grade Biosimilar
Target: Transforminggrowthfactorbeta-1proprotein,LAP,TGF-beta-1,TGFB1,TGFB
Purification: Protein A/G purified from cell culture supernatant.
Endotoxin level: <1EU/mg, determined by LAL gel clotting assay
Expression system: Mammalian Cells
Stability and Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Alternative Names: CAT-192,CAS:272780-74-2
Background: Transforming growth factor beta-1 proprotein (Transforming growth factor beta-1 proprotein,LAP,TGF-beta-1,TGFB1,TGFB) is a ~44 kDa protein. Transforming growth factor beta-1 proprotein: Precursor of the Latency-associated peptide (LAP) and Transforming growth factor beta-1 (TGF-beta-1) chains, which constitute the regulatory and active subunit of TGF-beta-1, respectively.
Note: For research use only. Not suitable for clinical or therapeutic use.